Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2003;89:14-18; doi:10.1136/heart.89.1.14
Copyright © 2003 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2003;89:14-18
© 2003 by Heart

REVIEW

Therapeutic inhibition of tumour necrosis factor {alpha} in patients with heart failure: cooling an inflamed heart

P A Henriksen, D E Newby

Department of Cardiology, University of Edinburgh, Royal Infirmary, Lauriston Place, Edinburgh, UK

Correspondence to:
Correspondence to:
Dr Peter Henriksen, Department of Cardiology, Royal Infirmary, Lauriston Place, Edinburgh EH3 9YW, UK;
p.henriksen{at}ed.ac.uk

ABSTRACT

Heart failure is a systemic disorder characterised by tissue hypoxia and secondary organ dysfunction which occurs in response to various myocardial insults that include ischaemia, viral infections, and toxins. In addition to maladaptive neurohumoral activation, heart failure is associated with an inflammatory state that appears to have a detrimental effect on cardiac function and prognosis. This has led to the suggestion that anti-inflammatory interventions may have therapeutic potential in the symptomatic and prognostic treatment of patients with heart failure. This review considers the role of inhibition of the cytokine tumour necrosis factor {alpha} in the treatment of heart failure.

Keywords: tumour necrosis factor {alpha}; heart failure

Abbreviations: ATTACH, anti-TNF alpha therapy against chronic heart failure; IL-1ß, interleukin 1ß; iNOS, inducible nitric oxide synthase; NF-{kappa}B, nuclear factor {kappa}B; RENAISSANCE, ramdomized etanercept North American strategy to study antagonism of cytokines; RECOVER, research into etanercept antagonism in ventricular dysfunction; TNF{alpha}, tumour necrosis factor {alpha}; TNFR, tumour necrosis factor {alpha} receptor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Yuan, Z, Liu, Y, Liu, Y, Zhang, J, Kishimoto, C, Wang, Y, Ma, A, Liu, Z (2005). Cardioprotective effects of peroxisome proliferator activated receptor {gamma} activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor {kappa}B blockade. Heart 91: 1203-1208 [Abstract] [Full Text]  
  • Meng, X., Ao, L., Song, Y., Raeburn, C. D., Fullerton, D. A., Harken, A. H. (2005). Signaling for myocardial depression in hemorrhagic shock: roles of Toll-like receptor 4 and p55 TNF-{alpha} receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R600-R606 [Abstract] [Full Text]  
  • Porter, K. E., Turner, N. A., O'Regan, D. J., Ball, S. G. (2004). Tumor necrosis factor {alpha} induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res 64: 507-515 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.